We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Luas Diagnostics (LD) aims to develop and market easy-to-use, rapid and accurate diagnostics tests with the aim of deploying these tests in remote settings away from centralised testing laboratories. The company has signed an exclusive distribution agreement with Chembio Diagnostics Systems (CDS) in the USA to market its Covid-19 antibody and antigen tests in the UK and Ireland. It has also signed a Memorandum of Understanding (MoU) with the University of Birmingham to develop saliva-based, rapid Covid-19 tests. LD is also working on coming up with a therapeutic drug monitoring system based on the same technology used worldwide to test people with diabetes for glucose levels in the blood. The company is developing the system so that it can be used at home, in pharmacies or GP surgery. The first product will test for Theophylline which is used to treat Chronic Obstructive Pulmonary Disease (COPD). LD will use the investment to grow its business across different verticals.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £326,190
Killing Kittens is a female empowerment brand that is leading a global movement to promote positivity for women, men and couples of all ages and sexualities. Its social media application has around 140,000 members worldwide, and the brand has hosted events in 12 countries. Killing Kitten's members use this platform to connect with like-minded people, improve their sex lives through education, and engage with brands and content. The company has raised £1 million in two previous successful funding rounds. In this round, 45% of the investment will be used for marketing, 45% for product innovation, 5% for preparing for funding, and 5% for operations.
days to go: Expired investment: £340,930
Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £200,000
Wooshii (www.wooshii.com) is a video production marketplace that matches clients to video producers.  
days to go: Expired investment: £302,000
THE MUGHALS is a prime-time entertainment drama series for international television, recreating for a modern audience the most vibrant ruling dynasty the world has known, in the genre of such hits as THE TUDORS and ROME.
days to go: Expired investment: £22,400
Aerobit is a smart inhaler, a tool for tracking medication use that records each time inhalers are taken and comes in a variety of cool toy designs. Built in sensors can even tell if the inhaler has been shaken correctly. 
days to go: Expired investment: £116,960
1854 Media is a multi-award-winning media brand powered by a global community of 2m+ creatives including many influential creators, media & arts institutions. It has been designed to discover and showcase the most talented, established, and emerging photographers, helping brands create imagery that cuts through the noise of 3 billion photos taken daily. Its exhibitions are seen by tens of millions with 90,000+ paid image entries. The company's mission is to become an essential platform for photographers by providing the vital tools they need to succeed. 1854 Media has 70% recurring customers since the last raise, and the company is now raising capital to accelerate growth.
days to go: Expired investment: £379,280
Chew is a live streaming community built for DJ's. Chew allows DJ's to share their mixes and help them to build a worldwide fan base.
days to go: Expired investment: £215,019
Thymia aims to empower clinicians with cutting-edge Neuroscience and AI objectively identify and track mental illness using speech, facial movements and behaviour patterns, enabling personalised, efficient treatment and accurate remote monitoring. They have a large dataset, successful sales, and are raising funds for medical regulation, ADHD expansion, and patent filings. 
days to go: Expired investment: £1,126,464
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
days to go: Expired investment: £451,506
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph